Jubilant Ingrevia profit and loss

Latest FY26

Revenue: ₹4,388cr+5.0% on FY25
EBITDA: ₹567cr+9.2% on FY25
Net profit: ₹278cr+10.6% on FY25
EPS: ₹17.59+10.7% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	4,924	4,388	4,178	4,136	4,773	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	38.0	40.5	37.8	35.3	33.4
	4,962	4,429	4,215	4,171	4,806
	2,523	2,105	2,050	2,040	2,548
	173	149	56.8	49.1	162
	−171	41.1	0.2	53.1	−128
	449	426	418	384	343
	64.2	49.1	55.6	52.7	21.6
	195	175	158	136	122
	1,249	1,101	1,133	1,188	1,301
	4,483	4,046	3,872	3,904	4,369
	701	567	519	421	547
	505	392	361	285	425
Profit
	479	383	344	268	437
	−13.0	−13.0	0.0	0.0	−0.0
	466	370	344	268	437
	112	84.2	85.3	63.6	70.2
	3.6	7.6	7.2	21.1	59.0
	115	91.8	92.4	84.7	129
	−0.1	−0.2	−0.0	0.0	0.0
	351	278	251	183	308
	351	278	251	183	308
	6.2	20.3	1.8	3.5	2.4
	357	298	253	186	310
	351	278	251	183	308
Per share
	₹22.21	₹17.59	₹15.89	₹11.56	₹19.34
	₹22.10	₹17.51	₹15.84	₹11.55	₹19.33
Revenue detail — as filed
	—	0.0	0.0	0.0	0.0
Other comprehensive income — detail
	6.2	20.3	1.8	—	—
	−6.8	0.9	−1.8	3.1	−1.7
	−1.1	0.1	−0.6	—	—
	—	—	—	0.1	−0.3
	12.5	26.2	4.1	0.1	3.2
	0.7	6.6	1.0	—	—
	—	—	—	−0.4	−0.6
	357	298	253	186	—
Per share — as-filed variants
	₹22.21	₹17.59	₹15.89	₹11.56	₹19.34
	₹22.10	₹17.51	₹15.84	₹11.55	₹19.33
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	2,399	2,093	2,070	1,993	2,191
	48.7%	47.7%	49.6%	48.2%	45.9%
Adjusted (ex-exceptional items) — derived
	479	383	344	268	437
	−13.0	−13.0	0.0	0.0	−0.0
	360	288	251	183	308
	₹22.83	₹18.21	₹15.89	₹11.56	₹19.34

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

JUBLINGREA₹604.00

Jubilant Ingrevia Ltd.

· Chemicals

Annual Quarterly₹ CrorePeersVIDHIING PARADEEP PCBL FACT OAL IGPL PAUSHAKLTD TIRUMALCHMMcap ₹9,543 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Revenue from Operations	4,772.7	4,135.8	4,177.6	4,388.1	4,924.1
Other Income	33.4	35.3	37.8	40.5	38.0
Total Income	4,806.1	4,171.1	4,215.4	4,428.6	4,962.1
Expenses
+ Cost of Materials Consumed	2,547.8	2,040.3	2,050.3	2,104.6	2,523.3
+ Purchases of Stock-in-Trade	161.6	49.1	56.8	149.0	173.0
+ Changes in Inventories	-127.7	53.1	0.2	41.1	-171.3
+ Employee Benefit Expense	343.5	384.0	418.1	425.6	449.4
+ Finance Costs	21.6	52.7	55.6	49.1	64.2
+ Depreciation & Amortisation	122.2	136.2	157.6	175.5	195.4
+ Other Expenses	1,300.5	1,188.2	1,133.2	1,100.7	1,249.1
Total Expenses	4,369.3	3,903.5	3,871.8	4,045.6	4,483.0
EBITDA	547.1	421.1	519.1	567.0	700.7
EBIT	425.0	285.0	361.5	391.6	505.3
Profit
PBT before Exceptional Items	436.8	267.6	343.6	383.0	479.1
+ Exceptional Items	-0.0	0.0	0.0	-13.0	-13.0
Pretax Income	436.7	267.6	343.6	369.9	466.1
+ Current Tax	70.2	63.6	85.3	84.2	111.8
+ Deferred Tax	59.0	21.1	7.2	7.6	3.6
Tax Expense	129.2	84.7	92.4	91.8	115.4
+ Share of Associates & JVs	0.0	0.0	-0.0	-0.2	-0.1
Net Income	307.5	182.9	251.2	277.9	350.6
+ Net Income — Continuing Ops	307.5	182.9	251.2	278.1	350.7
+ Other Comprehensive Income	2.4	3.5	1.8	20.3	6.2
Total Comprehensive Income	309.9	186.4	253.0	298.2	356.7
Net Income to Common	307.5	182.9	251.2	277.9	350.6
Per Share
Basic EPS	19.34	11.56	15.89	17.59	22.21
Diluted EPS	19.33	11.55	15.84	17.51	22.10
Revenue Detail — as filed
+ Share of P&L — Partnership Firms / LLPs	0.0	0.0	0.0	0.0	—
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	1.8	20.3	6.2
+ Items NOT to be Reclassified to P&L	-1.7	3.1	-1.8	0.9	-6.8
+ Tax on Items NOT to be Reclassified	—	—	-0.6	0.1	-1.1
+ Tax on Items NOT to be Reclassified — alt tag	-0.3	0.1	—	—	—
+ Items to be Reclassified to P&L	3.2	0.1	4.1	26.2	12.5
+ Tax on Items to be Reclassified	—	—	1.0	6.6	0.7
+ Tax on Items to be Reclassified — alt tag	-0.6	-0.4	—	—	—
Comprehensive Income — Owners of Parent	—	186.4	253.0	298.2	356.7
Per Share — as-filed variants
Basic EPS — Continuing Operations	19.34	11.56	15.89	17.59	22.21
Diluted EPS — Continuing Operations	19.33	11.55	15.84	17.51	22.10
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	2,191.1	1,993.2	2,070.3	2,093.3	2,399.1
Gross Margin %	45.91	48.19	49.56	47.70	48.72
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	436.8	267.6	343.6	383.0	479.1
− Exceptional Items (reconciliation)	-0.0	0.0	0.0	-13.0	-13.0
Net Income Adj (tax-effected)	307.5	182.9	251.2	287.7	360.4
EPS Adj	19.34	11.56	15.89	18.21	22.83
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	1.00	1.00	—	—	—
Filed Debt Equity	0.00	0.00	0.22	0.19	0.21
Filed Dscr	—	9.00	6.96	4.39	4.56
Filed Iscr	—	9.00	10.01	12.36	9.84
Paid Up Equity Capital	15.9	15.8	15.8	15.8	15.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.